{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:06:43Z","timestamp":1791176803829,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s11906-008-0020-3","type":"journal-article","created":{"date-parts":[[2008,4,26]],"date-time":"2008-04-26T11:19:26Z","timestamp":1209208766000},"page":"99-106","source":"Crossref","is-referenced-by-count":64,"title":["The role of the renin-angiotensin system in aortic aneurysmal diseases"],"prefix":"10.1007","volume":"10","author":[{"given":"Hong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L.","family":"Rateri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Cassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Daugherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,27]]},"reference":[{"key":"20_CR1","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.ATV.0000245819.32762.cb","volume":"26","author":"J. Golledge","year":"2006","unstructured":"Golledge J, Muller J, Daugherty A, Norman P: Abdominal aortic aneurysm. Pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006, 26:2605\u20132613.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.gde.2007.04.006","volume":"17","author":"F. Ramirez","year":"2007","unstructured":"Ramirez F, Dietz HC: Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev 2007, 17:252\u2013258.","journal-title":"Curr Opin Genet Dev"},{"key":"20_CR3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11906-004-0038-0","volume":"6","author":"A. Daugherty","year":"2004","unstructured":"Daugherty A, Cassis L: Angiotensin II and abdominal aortic aneurysms. Curr Hypertens Rep 2004, 6:442\u2013446.","journal-title":"Curr Hypertens Rep"},{"key":"20_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.ATV.0000118013.72016.ea","volume":"24","author":"A. Daugherty","year":"2004","unstructured":"Daugherty A, Cassis LA: Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004, 24:429\u2013434.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1999.tb07789.x","volume":"892","author":"A. Daugherty","year":"1999","unstructured":"Daugherty A, Cassis L: Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor-\/-mice. Ann N Y Acad Sci 1999, 892:108\u2013118.","journal-title":"Ann N Y Acad Sci"},{"key":"20_CR6","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","volume":"105","author":"A. Daugherty","year":"2000","unstructured":"Daugherty A, Manning MW, Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000, 105:1605\u20131612.","journal-title":"J Clin Invest"},{"key":"20_CR7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0002-9440(10)62532-1","volume":"159","author":"Y.X. Wang","year":"2001","unstructured":"Wang YX, Martin-McNulty B, Freay AD, et al.: Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 2001, 159:1455\u20131464.","journal-title":"Am J Pathol"},{"key":"20_CR8","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1161\/01.ATV.0000143384.69170.2d","volume":"24","author":"M. Ishibashi","year":"2004","unstructured":"Ishibashi M, Egashira K, Zhao Q, et al.: Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 2004, 24:e174\u2013e178.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000172631.50972.0f","volume":"25","author":"D. Gavrila","year":"2005","unstructured":"Gavrila D, Li WG, McCormick ML, et al.: Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005, 25:1671\u20131617.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjhyper.2004.11.005","volume":"18","author":"Y. Zhou","year":"2005","unstructured":"Zhou Y, Chen R, Catanzaro SE, et al.: Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice. Am J Hypertens 2005, 18:486\u2013492.","journal-title":"Am J Hypertens"},{"key":"20_CR11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.atherosclerosis.2005.05.016","volume":"184","author":"N. Ayabe","year":"2006","unstructured":"Ayabe N, Babaev VR, Tang Y, et al.: Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis 2006, 184:312\u2013321.","journal-title":"Atherosclerosis"},{"key":"20_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jss.2006.03.026","volume":"135","author":"M.J. Eagleton","year":"2006","unstructured":"Eagleton MJ, Ballard N, Lynch E, et al.: Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation. J Surg Res 2006, 135:345\u2013351.","journal-title":"J Surg Res"},{"key":"20_CR13","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/nm1335","volume":"11","author":"K. Yoshimura","year":"2005","unstructured":"Yoshimura K, Aoki H, Ikeda Y, et al.: Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 2005, 11:1330\u20131338.","journal-title":"Nat Med"},{"key":"20_CR14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.prostaglandins.2007.03.005","volume":"84","author":"R.Y. Cao","year":"2007","unstructured":"Cao RY, Adams MA, Habenicht AJ, Funk CD: Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice. Prostaglandins Other Lipid Mediat 2007, 84:34\u201342.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"20_CR15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4049\/jimmunol.179.1.691","volume":"179","author":"N. Ahluwalia","year":"2007","unstructured":"Ahluwalia N, Lin AY, Tager AM, et al.: Inhibited aortic aneurysm formation in BLT1-deficient mice. J Immunol 2007, 179:691\u2013697.","journal-title":"J Immunol"},{"key":"20_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000110041","volume":"45","author":"A. Vinh","year":"2007","unstructured":"Vinh A, Gaspari TA, Liu HB, et al.: A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. J Vasc Res 2007, 45:143\u2013152.","journal-title":"J Vasc Res"},{"key":"20_CR17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.RES.0000061571.49375.E1","volume":"92","author":"G.G. Deng","year":"2003","unstructured":"Deng GG, Martin-McNulty B, Sukovich DA, et al.: Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 2003, 92:510\u2013517.","journal-title":"Circ Res"},{"key":"20_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1191\/1358863x02vm413ra","volume":"7","author":"M.W. Manning","year":"2002","unstructured":"Manning MW, Cassis LA, Huang J, et al.: Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med 2002, 7:45\u201354.","journal-title":"Vasc Med"},{"key":"20_CR19","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1210\/en.2003-1615","volume":"145","author":"T.A. Henriques","year":"2004","unstructured":"Henriques TA, Huang J, D\u2019souza SS, et al.: Orchiectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E deficient mice. Endocrinology 2004, 145:3866\u20133872.","journal-title":"Endocrinology"},{"key":"20_CR20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.ATV.0000085631.76095.64","volume":"23","author":"K. Saraff","year":"2003","unstructured":"Saraff K, Babamusta F, Cassis LA, Daugherty A: Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:1621\u20131626.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jvs.2006.04.047","volume":"44","author":"C. Barisione","year":"2006","unstructured":"Barisione C, Charnigo RJ, Howatt DA, et al.: Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high frequency ultrasound. J Vasc Surg 2006, 44:372\u2013376.","journal-title":"J Vasc Surg"},{"key":"20_CR22","unstructured":"Rateri DL, Howatt DA, Xie X, et al.: Prolonged infusion of angiotensin II promotes abdominal aortic aneurysm remodeling associated with adventitial macrophage recruitment. Arterioscler Thromb Vasc Biol 2008, submitted."},{"key":"20_CR23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.ATV.0000106016.13624.4a","volume":"24","author":"J.T. Powell","year":"2004","unstructured":"Powell JT, Brady AR: Detection, management, and prospects for the medical treatment of small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004, 24:241\u2013245.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1067\/mva.2001.112810","volume":"33","author":"S. Liao","year":"2001","unstructured":"Liao S, Miralles M, Kelley BJ, et al.: Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001, 33:1057\u20131064.","journal-title":"J Vasc Surg"},{"key":"20_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1291\/hypres.30.349","volume":"30","author":"K. Furubayashi","year":"2007","unstructured":"Furubayashi K, Takai S, Jin D, et al.: The significance of chymase in the progression of abdominal aortic aneurysms in dogs. Hypertens Res 2007, 30:349\u2013357.","journal-title":"Hypertens Res"},{"key":"20_CR26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","volume":"134","author":"A. Daugherty","year":"2001","unstructured":"Daugherty A, Manning MW, Cassis LA: Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001, 134:865\u2013870.","journal-title":"Br J Pharmacol"},{"key":"20_CR27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.ATV.0000254680.71485.92","volume":"27","author":"L.A. Cassis","year":"2007","unstructured":"Cassis LA, Rateri DL, Lu H, Daugherty A: Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 2007, 27:380\u2013386.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjp.0706098","volume":"144","author":"L.A. Cassis","year":"2005","unstructured":"Cassis LA, Helton MJ, Howatt DA, et al.: Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Br J Pharmacol 2005, 144:443\u2013448.","journal-title":"Br J Pharmacol"},{"key":"20_CR29","unstructured":"Daugherty A, Ravisankar P, Szilvassy SJ, et al.: Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency. Arterioscler Thromb Vasc Biol 2008, submitted."},{"key":"20_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2006.10.015","volume":"73","author":"J.M. Gitlin","year":"2007","unstructured":"Gitlin JM, Trivedi DB, Langenbach R, Loftin CD: Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc Res 2007, 73:227\u2013236.","journal-title":"Cardiovasc Res"},{"key":"20_CR31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.ATV.0000216119.79008.ac","volume":"26","author":"V.L. King","year":"2006","unstructured":"King VL, Trivedi D, Gitlin JM, Loftin CD: Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler Thromb Vasc Biol 2006, 26:1137\u20131143.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR32","doi-asserted-by":"crossref","unstructured":"Zhang LN, Velichko S, Vincelette J, et al.: Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice. Atherosclerosis 2007, Epub ahead of print.","DOI":"10.1016\/j.atherosclerosis.2007.03.019"},{"key":"20_CR33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.ATV.0000058404.92759.32","volume":"23","author":"M.W. Manning","year":"2003","unstructured":"Manning MW, Cassis LA, Daugherty A: Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2003, 23:483\u2013488.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR34","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jvs.2007.06.022","volume":"46","author":"J. Wen","year":"2007","unstructured":"Wen J, Wang P, Smith SV, et al.: Syndecans are differentially expressed during the course of aortic aneurysm formation. J Vasc Surg 2007, 46:1014\u20131025.","journal-title":"J Vasc Surg"},{"key":"20_CR35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.bjp.0707449","volume":"152","author":"F. Jiang","year":"2007","unstructured":"Jiang F, Jones GT, Dusting GJ: Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein (E)-deficient mice. Br J Pharmacol 2007, 152:880\u2013890.","journal-title":"Br J Pharmacol"},{"key":"20_CR36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/CIRCULATIONAHA.105.607168","volume":"114","author":"M. Thomas","year":"2006","unstructured":"Thomas M, Gavrila D, McCormick ML, et al.: Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 2006, 114:404\u2013413.","journal-title":"Circulation"},{"key":"20_CR37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/HYPERTENSIONAHA.107.089706","volume":"50","author":"G. Gavazzi","year":"2007","unstructured":"Gavazzi G, Deffert C, Trocme C, et al.: NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 2007, 50:189\u2013196.","journal-title":"Hypertension"},{"key":"20_CR38","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/01.CIR.0000163544.17221.BE","volume":"111","author":"Y.X. Wang","year":"2005","unstructured":"Wang YX, Martin-McNulty B, da Cunha V, et al.: Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation 2005, 111:2219\u20132226.","journal-title":"Circulation"},{"key":"20_CR39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/01.ATV.0000085842.20866.6A","volume":"23","author":"B. Martin-McNulty","year":"2003","unstructured":"Martin-McNulty B, Tham DM, da Cunha V, et al.: 17 beta-estradiol attenuates development of angiotensin II induced aortic abdominal aneurysm in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:1627\u20131632.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20_CR40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejvs.2004.12.018","volume":"29","author":"C. Fatini","year":"2005","unstructured":"Fatini C, Pratesi G, Sofi F, et al.: ACE DD genotype: a predisposing factor for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2005, 29:227\u2013232.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"20_CR41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/ejvs.2002.1693","volume":"24","author":"J.M. Yeung","year":"2002","unstructured":"Yeung JM, Heeley M, Gray S, et al.: Does the angiotensin-converting enzyme (ACE) gene polymorphism affect rate of abdominal aortic aneurysm expansion? Eur J Vasc Endovasc Surg 2002, 24:69\u201371.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"20_CR42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejvs.2004.01.021","volume":"28","author":"M.W. Claridge","year":"2004","unstructured":"Claridge MW, Hobbs SD, Quick CR, et al.: ACE inhibitors increase type III collagen synthesis: a potential explanation for reduction in acute vascular events by ACE inhibitors. Eur J Vasc Endovasc Surg 2004, 28:67\u201370.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"20_CR43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jvs.2004.06.039","volume":"40","author":"G.M. Lloyd","year":"2004","unstructured":"Lloyd GM, Newton JD, Norwood MG, et al.: Patients with abdominal aortic aneurysm: are we missing the opportunity for cardiovascular risk reduction? J Vasc Surg 2004, 40:691\u2013697.","journal-title":"J Vasc Surg"},{"key":"20_CR44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(06)69250-7","volume":"368","author":"D.G. Hackam","year":"2006","unstructured":"Hackam DG, Thiruchelvam D, Redelmeier DA: Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 2006, 368:659\u2013665.","journal-title":"Lancet"},{"key":"20_CR45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.1999.tb07682.x","volume":"878","author":"R.W. Thompson","year":"1999","unstructured":"Thompson RW, Baxter BT: MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann N Y Acad Sci 1999, 878:159\u2013178.","journal-title":"Ann N Y Acad Sci"},{"key":"20_CR46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"J.P. Habashi","year":"2006","unstructured":"Habashi JP, Judge DP, Holm TM, et al.: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312:117\u2013121.","journal-title":"Science"},{"key":"20_CR47","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/hmg\/ddm201","volume":"16","author":"H. Pannu","year":"2007","unstructured":"Pannu H, Tran-Fadulu V, Papke CL, et al.: MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet 2007, 16:3453\u20133462.","journal-title":"Hum Mol Genet"},{"key":"20_CR48","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.amjcard.2005.01.032","volume":"95","author":"A.T. Yetman","year":"2005","unstructured":"Yetman AT, Bornemeier RA, McCrindle BW: Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol 2005, 95:1125\u20131127.","journal-title":"Am J Cardiol"},{"key":"20_CR49","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.298.13.1539","volume":"298","author":"A.A. Ahimastos","year":"2007","unstructured":"Ahimastos AA, Aggarwal A, D\u2019Orsa KM, et al.: Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA 2007, 298:1539\u20131547.","journal-title":"JAMA"},{"key":"20_CR50","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ahj.2007.06.024","volume":"154","author":"R.V. Lacro","year":"2007","unstructured":"Lacro RV, Dietz HC, Wruck LM, et al.: Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J 2007, 154:624\u2013631.","journal-title":"Am Heart J"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-008-0020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-008-0020-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-008-0020-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:14:20Z","timestamp":1559434460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-008-0020-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1007\/s11906-008-0020-3","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}